€10M investment boosts Finnish capabilities in cancer immunotherapy
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program. This University of Helsinki […]
€10M investment boosts Finnish capabilities in cancer immunotherapy Read More »









